跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,709 条关于
“Fresenius Group”
全部
26,709
临床试验
18,051
药物
579
机构
537
资讯
7,542
去年
Leon-nanodrugs Appoints Dr. Wolfgang Hofmann as CEO to Drive Nanoparticle Manufacturing Technology Commercialization
去年
Polpharma Biologics and Fresenius Kabi Partner on Vedolizumab Biosimilar for Inflammatory Bowel Disease
去年
Fresenius Kabi Launches 30 mg/30 mL Epinephrine Injection for Emergency Care and Septic Shock
去年
Teva and mAbxience Expand Partnership with New PD-1 Biosimilar Candidate
上个月
Fresenius Launches €200M+ Corporate Venture Fund to Tap Early-Stage Healthcare Innovation
上个月
Analysts Maintain Buy Ratings on Fresenius SE & Co. KGaA Amid Positive Insider Sentiment
去年
Fresenius Kabi Launches Epinephrine Injection, USP Expanding ...
去年
FDA Approves Otulfi, a Stelara Biosimilar, for Inflammatory Conditions
2年前
First RoActemra Biosimilar Tyenne Receives EU Approval, Marking Milestone for Fresenius Kabi
去年
Amgen and Fresenius Kabi Reach Settlement in Denosumab Biosimilar Litigation
第 1 页,共 755 页
上一页
下一页